1. Antitumor activity of lurbinectedin in second-line small cell lung cancer patients who are candidates for re-challenge with the first-line treatment. (December 2020) Authors: Subbiah, Vivek; Paz-Ares, Luis; Besse, Benjamin; Moreno, Victor; Peters, Solange; Sala, María Angeles; López-Vilariño, José Antonio; Fernández, Cristian; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Zeaiter, Ali; Zaman, Khalil; López, Rafael; Ponce, Santiago; Boni, Valentina; Arrondeau, Jen... Journal: Lung cancer Issue: Volume 150(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATLANTIS: a Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line. (26th October 2018) Authors: Farago, Anna F; Drapkin, Benjamin J; Lopez-Vilarino de Ramos, Jose Antonio; Galmarini, Carlos M; Núñez, Rafael; Kahatt, Carmen; Paz-Ares, Luis Journal: Future oncology Issue: Volume 15:Number 3(2019) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. Issue 4 (April 2016) Authors: Berthon, Céline; Raffoux, Emmanuel; Thomas, Xavier; Vey, Norbert; Gomez-Roca, Carlos; Yee, Karen; Taussig, David Christopher; Rezai, Keyvan; Roumier, Christophe; Herait, Patrice; Kahatt, Carmen; Quesnel, Bruno; Michallet, Mauricette; Recher, Christian; Lokiec, François; Preudhomme, Claude; Dombre... Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Issue 4 (April 2016) Authors: Amorim, Sandy; Stathis, Anastasios; Gleeson, Mary; Iyengar, Sunil; Magarotto, Valeria; Leleu, Xavier; Morschhauser, Franck; Karlin, Lionel; Broussais, Florence; Rezai, Keyvan; Herait, Patrice; Kahatt, Carmen; Lokiec, François; Salles, Gilles; Facon, Thierry; Palumbo, Antonio; Cunningham, David; Z... Journal: Lancet Issue: Volume 3:Issue 4(2016) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Aix, Santiago Ponce; Ciuleanu, Tudor Eliade; Navarro, Alejandro; Cousin, Sophie; Bonanno, Laura; Smit, Egbert F; Chiappori, Alberto; Olmedo, Maria Eugenia; Horvath, Ildiko; Grohé, Christian; Farago, Anna F; López-Vilariño, José Antonio; Cullell-Young, Martin; Nieto, Antonio; Vasco, Noelia; Gómez,... Journal: Lancet Issue: Volume 11:Issue 1(2023) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study. Issue 11 (5th November 2021) Authors: Kristeleit, Rebecca; Moreno, Victor; Boni, Valentina; Guerra, Eva M; Kahatt, Carmen; Romero, Ignacio; Calvo, Emiliano; Basté, Neus; López-Vilariño, José A; Siguero, Mariano; Alfaro, Vicente; Zeaiter, Ali; Forster, Martin Journal: International journal of gynecological cancer Issue: Volume 31:Issue 11(2021) Page Start: 1428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Doxorubicin plus lurbinectedin in patients with advanced endometrial cancer: results from an expanded phase I study. Issue 11 (5th October 2021) Authors: Kristeleit, Rebecca; Moreno, Victor; Boni, Valentina; Guerra, Eva M; Kahatt, Carmen; Romero, Ignacio; Calvo, Emiliano; Basté, Neus; López-Vilariño, José A; Siguero, Mariano; Alfaro, Vicente; Zeaiter, Ali; Forster, Martin Journal: International journal of gynecological cancer Issue: Volume 31:Issue 11(2021) Page Start: 1428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial. (August 2017) Authors: Ghouadni, Amal; Delaloge, Suzette; Lardelli, Pilar; Kahatt, Carmen; Byrski, Tomasz; Blum, Joanne L.; Gonçalves, Anthony; Campone, Mario; Nieto, Antonio; Alfaro, Vicente; Cullell-Young, Martin; Lubinski, Jan Journal: Breast Issue: Volume 34(2017) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models. Issue 12 (15th October 2019) Authors: Astorgues-Xerri, Lucile; Vázquez, Ramiro; Odore, Elodie; Rezai, Keyvan; Kahatt, Carmen; Mackenzie, Sarah; Bekradda, Mohamed; Coudé, Marie-Magdelaine; Dombret, Herve; Gardin, Claude; Lokiec, Francois; Raymond, Eric; Noel, Kay; Cvitkovic, Esteban; Herait, Patrice; Bertoni, Francesco; Riveiro, María E. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 12(2019) Page Start: 3067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial. Issue 5 (May 2020) Authors: Trigo, José; Subbiah, Vivek; Besse, Benjamin; Moreno, Victor; López, Rafael; Sala, María Angeles; Peters, Solange; Ponce, Santiago; Fernández, Cristian; Alfaro, Vicente; Gómez, Javier; Kahatt, Carmen; Zeaiter, Ali; Zaman, Khalil; Boni, Valentina; Arrondeau, Jennifer; Martínez, Maite; Delord, Jean... Journal: Lancet oncology Issue: Volume 21:Issue 5(2020) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗